Global Lymphedema Diagnostics Market, By Type (Primary, Secondary), Technology (Lymphoscintigraphy, Magnetic Resonance Imaging, Ultrasound Imaging, Computed Tomography, X-Ray Lymphography, Bio-impedance Analysis, Near-Infrared Fluorescence Imaging), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular Disease, Other Diseases), Treatment Type (Surgery, Compression Therapy, Others), End User (Hospitals, Diagnostic Centers, Research and Academic Institutes , Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights of Lymphedema Diagnostics Market
Lymphedema diagnostics market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 7.6% in the above-mentioned forecast period.
Lymphedema is basically a chronic illness that is generally characterized by swelling in any area of the body's tissues, most notably the arms and legs. It arises as a result of lymphatic system injury. It can also arise following breast cancer treatment. Given the history of a surgical operation or another condition that includes lymph node injury, the diagnosis of lymphedema is frequently obvious.
The growing incidence of chronic diseases such as cancer and lymphedema coupled with the increasing focus of quality of healthcare are the significant factors responsible for driving the growth of the lymphedema diagnostics market in the above-mentioned forecast period. Additionally, the rising investment and innovation of newer diagnostics modalities and the rising growth of the emerging countries such as China, India, Brazil, South Korea and Russia also heighten the overall growth of the market. However, the high cost of diagnostic imaging systems obstruct the market’s growth. The limited supply of helium also restricts the market’s growth.
The various technological advancements in diagnostic imaging modalities and increasing investments, funds, and grants by public-private organizations are expected to generate profitable opportunities for the market. On the other hand, the increasing adoption of refurbished diagnostic imaging systems have the potential to challenge for the market’s growth.
This lymphedema diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research lymphedema diagnostics market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Lymphedema Diagnostics Market Scope and Market Size
Lymphedema diagnostics market is segmented on the basis of type, technology, disease type, treatment type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the lymphedema diagnostics market is segmented into primary and secondary.
- On the basis of technology, the lymphedema diagnostics market is segmented into lymphoscintigraphy, magnetic resonance imaging, ultrasound imaging, computed tomography, x-ray lymphography, bioimpedance analysis and near-infrared fluorescence imaging. Near-Infrared fluorescence imaging is further segmented into ICG lymphography and fluorescein sodium microlymphangiography. Lymphoscintigraphy segment holds the largest share due to the non-invasive nature and easy availability of the technology.
- The lymphedema diagnostics market has also been segmented on the basis of disease type into cancer, inflammatory diseases, cardiovascular diseases, and other diseases. Cancer segment holds the largest market share due to the rising awareness regarding the early diagnosis and occurrence of cancer related lymphedema.
- On the basis of treatment type, market is segmented into surgery, compression therapy and others.
- On the basis of type, the lymphedema diagnostics market is segmented into hospitals, diagnostic centres, research and academic institutes, others. Hospital segment accounted for the largest share in the market due to the adoption of minimally invasive procedure and the improvement of workflow efficiency in hospitals.
Lymphedema Diagnostics Market Country Level Analysis
Lymphedema diagnostics market is segmented on the basis of type, technology, disease type, treatment type and end user.
The countries covered in the lymphedema diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to the easy availability of the healthcare system. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the untapped growth opportunities in the region especially in, Japan, China, and India. The rising occurrence of chronic diseases and rising awareness about the early benefits.
The country section of the lymphedema diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Lymphedema diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for lymphedema diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the lymphedema diagnostics market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Lymphedema Diagnostics Market Share Analysis
Lymphedema diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to lymphedema diagnostics market.
Some of the major players operating in the lymphedema diagnostics market report are Shimadzu Corporation, Fluoptics, BIOCOMPRESSION SYSTEMS, Lohmann & Rauscher GmbH & Co. KG, Mego Afek ltd., SIGVARIS Group, Tactile Medical., PAUL HARTMANN AG, 3M, Convatec Inc., JUZO, SIGVARIS GROUP, Tactile Medical, BIOCOMPRESSION SYSTEMS, ThermoTek, Cardinal Health, Essity (BSN medical GmbH), Smith+Nephew HERANTIS PHARMA Plc, Stryker, Mitaka USA Inc., and ImpediMed Limited and ImpediMed Inc., among others.
SKU-
